跳至主要内容
临床试验/NCT03479489
NCT03479489已完成不适用

A Prospective Case Series for Closed Hemorrhoidectomy - Efficacy of External Hemorrhoid Repair Using a Dehydrated Human Amnion Chorion Membrane

MiMedx Group, Inc.2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2018年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
2
主要终点
Reported Patient Pain

研究概览

简要总结

The purpose of this study is to determine the safety and effectiveness of human dehydrated amnion chorion allograft in closed hemorrhoidectomy as assessed by patient and wound assessments.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of acutely thrombosed hemorrhoid or an external hemorrhoid exceeding 72 hours in duration
  • Subject is undergoing closed hemorrhoidectomy as their definitive treatment for the Grade 2-4 hemorrhoid
  • Subject is age 18 or older
  • Subject is willing and able to provide informed consent and participate in all procedures and follow-up evaluations necessary to complete the study

排除标准

  • Subject has a known history of poor compliance with medical treatments
  • Subject has signs and symptoms of active cirrhosis
  • Subject has signs and symptoms of Crohn's disease complicated by perianal manifestations
  • Subject is currently taking immunosuppressive medications
  • Subject has had previous surgery in the target area within the past 6 months prior to treatment or plans to have surgery other than closed hemorrhoidectomy in the target area within 180 days of treatment
  • Subject is currently receiving radiation therapy or chemotherapy
  • Subject has used an investigational drug, device or biologic within 12 weeks prior to treatment
  • Subject is pregnant at enrollment or is planning to become pregnant within 180 days of treatment; subject intends to breastfeed during the course of the trial
  • Subject has any significant medical condition(s) that, in the opinion of the Investigator, would interfere with protocol evaluation and participation
  • Subject has an allergy or known sensitivity to aminoglycoside antibiotics such as gentamicin sulfate and/or streptomycin sulfate

结局指标

主要结局

Reported Patient Pain

时间窗: 60 days

The primary endpoint of the study is the change in patient reported pain across four categories from baseline within the 60 day follow-up period. In every patient diary, subjects will be asked to assess their pain on a 10 point Likert scale under the following conditions * Do you experience pain continuously? * Do you experience pain with activity? * Do you experience pain while sitting? * Do you experience pain with bowel movements?

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验